Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial

Objective To assess the efficacy and safety of varenicline (a licensed cigarette smoking cessation aid) in helping users of smokeless tobacco to quit. Design Double blind, placebo controlled, parallel group, multicentre, randomised controlled trial. Setting Medical clinics (mostly primary care) in N...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagerström, Karl, Gilljam, Hans, Metcalfe, Michael, Tonstad, Serena, Messig, Michael
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997603/
https://www.ncbi.nlm.nih.gov/pubmed/21134997
http://dx.doi.org/10.1136/bmj.c6549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997603/
https://www.ncbi.nlm.nih.gov/pubmed/21134997
http://dx.doi.org/10.1136/bmj.c6549

Ejemplares similares